Tonix Pharmaceuticals, Inc.
509 Madison Ave.
271 articles with Tonix Pharmaceuticals, Inc.
TONIX Pharmaceuticals, Inc. to Present at the 14th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference on February 14, 2012
TONIX Pharmaceuticals, Inc. to Present at Biotech Showcase and OneMedForum Conferences in San Francisco on January 9 and 10, 2012
TONIX Pharmaceuticals, Inc. to Present at the New York Society of Security Analysts' 15th Annual Biotech and Specialty Pharmaceuticals Conference on November 30, 2011
TONIX Pharmaceuticals, Inc. Receives FDA Clearance to Initiate a Pharmacokinetic Study of TNX-102 for Fibromyalgia
TONIX Pharmaceuticals, Inc. and Tamandare Explorations Announce Completion of Share Exchange Transaction and Private Placement
TONIX Pharmaceuticals, Inc.' Bedtime Very Low Dose Cyclobenzaprine Study Featured in Journal of Rheumatology
TONIX Pharmaceuticals, Inc. Presents Findings on the Effects of Bedtime Very Low Dose (VLD) Cyclobenzaprine (CBP) on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome
TONIX Pharmaceuticals, Inc. to Present at the OneMedForum San Francisco 2011 on January 11 and at the Biotech Showcase on January 12